Tjebo Heeren

11PUBLICATIONS
41CO-AUTHORS
PharmacogenomicsVision scienceEpidemiological modellingOptical technologyBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 17, 2026
Azithromycin versus azithromycin-pyrimethamine and sulfadiazine-pyrimethamine for the treatment of ocular toxoplasmosis: a retrospective comparative case-series.

|Mar 02, 2026
Predictive factors for visual acuity in diabetic macular oedema: lessons for clinical practice learned from deferring intravitreal injections under the COVID-19 pandemic.

Marcela Bohn, Jose Carlo M Artiaga, Tjebo Heeren

|Jul 16, 2025
Impact of anti-VEGF treatment for diabetic macular oedema on progression to proliferative diabetic retinopathy: data-driven insights from a multicentre study.

Abraham Olvera-Barrios, Watjana Lilaonitkul, Tjebo F C Heeren

|Jul 24, 2023
A Novel Role for Corneal Pachymetry in Planning Cataract Surgery by Determining Changes in Spherical Equivalent Resulting from a Previous LASIK Treatment.

Arthur Hammer, Tjebo F C Heeren, Romesh Angunawela

|Sep 18, 2021
Effect of ethnicity and other sociodemographic factors on attendance at diabetic eye screening: a 12-month retrospective cohort study.

Abraham Olvera-Barrios, Michael Seltene, Tjebo F C Heeren

|Jul 24, 2020
Systemic lipid dysregulation is a risk factor for macular neurodegenerative disease.

Roberto Bonelli, Sasha M Woods, Brendan R E Ansell

Pageof 2

Frequent Collaborators

3 joint publications

Peter Charbel Issa

3 joint publications

Abraham Olvera-Barrios

2 joint publications

Catherine Egan

2 joint publications

Marcela Bohn